Summit Creek Advisors LLC Invests $8.55 Million in Addus HomeCare Corporation $ADUS

Summit Creek Advisors LLC purchased a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 85,118 shares of the company’s stock, valued at approximately $8,552,000. Addus HomeCare accounts for approximately 2.9% of Summit Creek Advisors LLC’s investment portfolio, making the stock its 5th largest holding.

Other hedge funds and other institutional investors have also modified their holdings of the company. Global Retirement Partners LLC lifted its holdings in Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC raised its position in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after buying an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC bought a new stake in shares of Addus HomeCare during the 4th quarter worth about $29,000. Private Trust Co. NA lifted its stake in shares of Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares during the period. Finally, Arax Advisory Partners lifted its stake in shares of Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after acquiring an additional 137 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Up 2.8%

NASDAQ ADUS opened at $118.13 on Wednesday. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The company has a market capitalization of $2.21 billion, a P/E ratio of 20.72, a PEG ratio of 1.56 and a beta of 0.87. The company’s 50 day simple moving average is $107.83 and its 200 day simple moving average is $102.12. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to analysts’ expectations of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period last year, the firm posted $1.49 earnings per share. Equities research analysts expect that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. The trade was a 0.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ADUS. Royal Bank Of Canada raised their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Barclays increased their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $130.88.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.